Skip to content

Influence of Bedrest and Hypocaloric Nutrition on Endothelium-Dependent Vasoreactivity

Influence of Bed-Rest and Hypocaloric Nutrition on Endothelium-Dependent Vasoreactivity

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00175968
Enrollment
10
Registered
2005-09-15
Start date
2001-03-31
Completion date
2003-04-30
Last updated
2005-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Aim of the study is to assess the impact of the factors ´bed rest´ and ´hypocaloric nutrition´ on endothelium-dependent vasoreactivity in healthy volunteers.

Detailed description

In a randomized, four-phase cross-over study the effect of simulated microgravity (13 days of bed rest), energetic restriction (-25%, fat reduced), and their combination on endothelium-dependent and -independent vasodilation will be compared with ambulatory control conditions. Using venous occlusion plethysmography cumulative intraarterial dose-response curves to endothelium-dependent (acetylcholine) and -independent (sodium nitroprusside) vasodilators will be constructed in 10 healthy male volunteers before and on day 13 of each of the four intervention periods.

Interventions

PROCEDUREbed rest, hypocaloric nutrition

Sponsors

Heidelberg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
ECT
Masking
SINGLE

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

´ * Healthy, male volunteers, age: 18-40 * Able and willing to give written informed consent

Exclusion criteria

* Known condition causing endothelial dysfunction (e.g. diabetes, hyperlipidaemia, arterial hypertension, smoking, hyperhomocysteinaemia) * Regular medication and/or treatment with drugs within the last 4-6 weeks (exclusion has to be decided in each case) * Acute or chronic illness * Participation in clinical trial/blood donation within 2 month before the study * Nicotine during 1 year before the study; drug and/or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
Drug-induced changes of forearm blood flow

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026